British Fertility Society Statement on Reproductive
Immunotherapy
17 January 2007
Many patients will have understandable concerns with respect to
the issues raised in the recent Panorama programme, and in particular
about immunotherapy in the treatment of infertility.
The BFS has stated that there is no convincing research evidence
to suggest that immunotherapy is indicated in this situation. Where
consideration is being given to the use of this form of treatment,
it is the view of the Society that this should only be offered
in the context of a properly conducted clinical trial. Research
methodology, patient information and consent procedures will have
been scrutinised in these circumstances by a research ethics committee
and issues, particularly in relation to effectiveness and potential
harm, will have undergone careful evaluation within this framework.
For the moment, it is the view of the BFS that the public should
be advised there is no substantive evidence of benefit or harm
to patients, or their children, with this form of treatment.
Patients who have worries in relation to their own clinical situation
should discuss matters with the health professional involved in
their care.
Dr Mark Hamilton (Chair)
For more information: please contact the British Fertility Society press office
|